CINBIOS informs you about important regional and national industrial life sciences news. If your news is of interest to the life sciences community, we will post it on our website.
A positive result of 1 259 413 EUR or 0.37 EUR per share was recorded during 3Q 2009, limiting the loss incurred since the start of the year to 90 290 EUR or 0.03 EUR per share. The bullish stock markets boosted the value of the listed portfolio. No value adjustments were carried out in the unlisted portfolio during the third quarter. read more